维普中文期刊产品整合服务
23篇 您的检索式:作者名="Camarri"
    题名 作者 年代 出处 被引量
1Otilonium bromide in the irritable bowel syndrome:a double-blind,placebo-controlled,15 week study显示文摘Battaglia G Marselli-Labate AM Camarri E 1998Aliment Pharmacol Ther1998,12,:1
2Large-eddy simulation of the flow around a triangular prism with moderate aspect ratio 显示文摘Camarri S Salvetti M V Buresti G 2006Journal of Wind Engineering and Industrial Aerodynamics2006,94,5:1
3Otilonium bromide in the irritable bowel syndrome:a double-blind,placebo controlled,15 weeks study in a large number of patients显示文摘Battaglia G Morseli Labate A M Camarri E 1998Aliment Pharmacol Ther1998,12,10:1
4Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis:a randomized double-blind study显示文摘D'Albosio G Pacini F Camarri E 1997Am J Gastroenterol1997,92,7:1
5Otilonium bromide in the irritable syndrome: a double- blind, Placebo controlled 15 weeks study in a large number of patients 显示文摘Battaglia G Morselli - Labate AM Camarri E 1998Aliment Pharmacol Ther1998,12,10:1
6Otilonium bro- mide in the irritable bowel syndrome: a double-blind, placebo con- trolled, 15 weeks study 显示文摘Battaglia G Morselli-Labate AM Camarri E 1998Aliment Phammcol Ther1998,12,10:1
7Otilonium bromide in irritable bowel syndrome: a double‐blind, placebo‐controlled, 15‐week study显示文摘Battaglia Morselli‐Labate Camarri Francavilla Marco Mastropaolo Naccarato 2001Alimentary Pharmacology & Therapeutics2001,,10:1
8Otilomium bromide in the irritable syndrome:a double-blind,Placebo controlled 15 weeks study in a large number of patients显示文摘Battaglia G Morselli-Labate AM Camarri E 1998Aliment Pharmacol Ther1998,12,10:1
9Otilonium bromide in the irritable bowel syndrome; adoubleblind, placebo controlle, 15 weeks study in a large number of patients显示文摘Battaglia G Morseli-Labate AM Camarri E 1998Aliment Pharmacol Ther1998,12,10:1
10Combined therapy with 5-aminoalicyclic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study显示文摘Albasio G Pacini F Camarri E Messori A Trauori G Bonanomi AG Bardazzi G Milla M Ferrero S Biaginim Quaranta S Amorosi A 1997American Journal of Gastroenterology1997,92,11:1
11An RPC γ irradiation test显示文摘AIELLI G CAMARRI P CARDARELLI R 2000Nucl Instrum Methods A2000,456,:1
12Six minute walkdistance in healthy subjects aged 55-75 years 显示文摘Camarri B Eastwood PR Cecins NM 2006Respir Med2006,100,4:1
13Otilonium bromide in the irritable bowel syndrome: a double - blind, placebo controlled,15 weeks study in a large number of patients 显示文摘Battaglia G Morselli - Labate AM Camarri E 1998Aliment Pharmacol Ther1998,12,:1
14Large-eddy simulation of a bluff-body flow on unstructured grids显示文摘Camarri S Salvetti M V Koobus B Dervieux A 2002Int J Numer Meth Fluids2002,40,:1
15Otilonium bromide in the irritable bowel syndrome:a double blind,placebo controlled 15 weekes study in a large number of patients显示文摘Battaglia G Morselli-Labate AM CaMarri E 1998Aliment Pharmachol Ther1998,12,10:1
16Otilonium bro- mide in the irritable bowel syndrome: a double-blind, placebo con- trolled,15 weeks study in a large number of patients显示文摘Battaglia G Morseli Labate AM Camarri E 1998Aliment Pbarmacol Tber1998,12,10:1
17Six minute walk dis- tanee in healthy subjects aged 55-75 years 显示文摘Camarri B Eastwand PR Ceeins NM 2006Respir Mecl2006,100,4:1
18Otilonium bromide in irritable bowel syndrome a double-blind, placebo- controlled, 15-week study 显示文摘Battaglia G Morselli-Labate AM Camarri E 1998Aliment Pharmacol Ther1998,12,10:1
19Otilonium bromide in irritable bowel syndrome a double-blind, placebo-controlled, 15 week-study显示文摘 MOTSELLI-LABATE AM CAMARRI E 1998Aliment Pharmcol Ther1998,12,10:1
20Otilonium bromide in the irritable bowel syndrome: a double-blind, placebo controlled, 15 weeks study in a large number of patients显示文摘Battaglia G Morseli-Labate AM Camarri E 1998Aliment Pharmacol Ther1998,12,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费